Bonello Michael J. 4

4 · PRA Health Sciences, Inc. · Filed Jun 21, 2021

Form 4

Period: 2021-06-17

Exec VP & CFO

Transactions

Exercise/Conversion
Common Stock
2021-06-17$103.30/sh+8,556$883,835→ 64,415 total
Sale
Common Stock
2021-06-17$168.17/sh−24,389$4,101,498→ 39,826 total
Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−35,661→ 20,000 total
Exercise: $81.61Exp: 2028-04-26→ Common Stock (35,661 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−8,334→ 16,666 total
Exercise: $95.94Exp: 2029-08-13→ Common Stock (8,334 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−8,556→ 17,114 total
Exercise: $103.30Exp: 2030-06-01→ Common Stock (8,556 underlying)
Exercise/Conversion
Common Stock
2021-06-17$81.61/sh+35,661$2,910,294→ 47,525 total
Sale
Common Stock
2021-06-17$166.70/sh−200$33,340→ 64,215 total
Sale
Common Stock
2021-06-17$169.05/sh−22,587$3,818,332→ 17,239 total
Sale
Common Stock
2021-06-17$169.67/sh−5,375$911,976→ 11,864 total
Exercise/Conversion
Common Stock
2021-06-17$95.94/sh+8,334$799,564→ 55,859 total

Footnotes (8)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.55 to $166.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) of this Form 4.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.57 to $168.56, inclusive.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.57 to $169.55, inclusive.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.57 to $169.83, inclusive.
[F6]12,877 options vested on April 26, 2019 and 4,339 options vested on April 26, 2020 upon satisfaction of certain performance criteria.
[F7]The option vests in three equal annual installments of 8,334 beginning on August 13, 2020.
[F8]The option vests in three equal annual installments of 8,556 beginning on June 1, 2021.

Documents

1 file